Mindpeak: Mindpeak’s PD-L1 Lung AI achieves 92% concordance in clinical DRT test without human intervention. Mindpeak's AI software for scoring PD-L1 in non-small cell lung cancer (NSCLC) has passed the Digital Readout Test (DRT) of German...

Mindpeak breast cancer algorithms have been seamlessly integrated into the gold-standard image management software, CaloPix 5, enhancing the pathologist's possibilities. PARIS, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Tribun Health, the European...

(PresseBox) (Hamburg, 20.07.2022) Mindpeak announces the CE-mark for another new product: Mindpeak Breast HER2 RoI (Region of Interest) supports pathologists in the scoring of digital images of breast cancer tissue, which underwent...

Mindpeak announces scanner agnostic CE-marked PD-L1 AI solution to support Lung Cancer Diagnosis (PresseBox) (Hamburg, 06/09/2022) -- Mindpeak, European leader in Artificial Intelligence in Pathology, today announced the launch of a new CE...

Geneva, 30 March 2022: Unilabs, the leading diagnostic services provider, has signed an agreement with Mindpeak, an AI solutions provider for digital pathology. Mindpeak’s AI technology will speed up breast cancer screening and make it more...

Mountain View, California, February 28, 2022 – Crosscope Inc. a leading provider of AI-enabled digital pathology software and Mindpeak Gmbh, known for building sophisticated AI tools for clinical diagnosis, today announced their...